MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transport
about
The rebel angel: mutant p53 as the driving oncogene in breast cancer.Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma.Resistance acquisition to MDM2 inhibitors.Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastoma.
P2860
MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transport
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MDM2 antagonist nutlin-3a reve ...... rotein mediated drug transport
@ast
MDM2 antagonist nutlin-3a reve ...... rotein mediated drug transport
@en
type
label
MDM2 antagonist nutlin-3a reve ...... rotein mediated drug transport
@ast
MDM2 antagonist nutlin-3a reve ...... rotein mediated drug transport
@en
prefLabel
MDM2 antagonist nutlin-3a reve ...... rotein mediated drug transport
@ast
MDM2 antagonist nutlin-3a reve ...... rotein mediated drug transport
@en
P2093
P2860
P1476
MDM2 antagonist nutlin-3a reve ...... rotein mediated drug transport
@en
P2093
Clinton F Stewart
D Steven Zatechka
Laura A Miller
Laura L Murley
R Kiplin Guy
Rachel Kennedy
Stacy L Throm
P2860
P356
10.1016/J.BCP.2011.03.024
P407
P577
2011-04-01T00:00:00Z